At this webinar we hear from Dr Clare Thibodeaux, Vice President of Scientific Affairs at Cures Within Reach, a US-based nonprofit focused specifically on repurposing research, who shares specific examples and success stories from the work of Cures Within Reach.

Drug repurposing – testing already approved therapies in new indications – deliver treatments to patients faster and offers opportunities to address unmet medical needs. However, moving a repurposed therapy through the research pipeline, from basic research to preclinical studies to proof-of-concept clinical trials, still presents some challenges. This webinar focuses on drug repurposing as a drug development strategy, providing insights on how preclinical repurposing research can lead to clinical repurposing trials. During her talk Dr Thibodeaux presents an introduction to drug repurposing, and she addresses topics such as how preclinical research can inform the design of clinical repurposing trials and how repurposing research can be funded.

The webinar was chaired by Dr Frank Wessely, Research Associate at Dementia Research Institute (Cardiff University), and one of the Programme coordinators of our related ‘Drug repurposing II’ conference that it's being held in London on the 10-11 May 2022. For more information, please visit the event website at: http://bit.ly/Drug-repurposing-II